Journal
PHARMACOLOGICAL RESEARCH
Volume 197, Issue -, Pages -Publisher
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.phrs.2023.106967
Keywords
Pharmacovigilance; Adverse drug reaction; Pharmacoepidemiology; Effectiveness; Efficiency; Real world evidence; Pharmacoeconomics; Health technology assessment
Categories
Ask authors/readers for more resources
Clinical pharmacology should shift its focus from drug-individual interaction to drug-individual-society interaction and analyze the clinical and economic consequences of drug use in clinical practice. The current technological development offers an opportunity for exploration in other areas of interest.
Traditionally, clinical pharmacology has focused its activities on drug-organism interaction, from an individual or collective perspective. Drug efficacy assessment by performing randomized clinical trials and analysis of drug use in clinical practice by carrying out drug utilization studies have also been other areas of interest. From now on, Clinical pharmacology should move from the analysis of the drug-individual interaction to the analysis of the drug-individual-society interaction. It should also analyze the clinical and economic consequences of the use of drugs in the conditions of normal clinical practice, beyond clinical trials. The current exponential technological development that facilitates the analysis of real-life data offers us a golden opportunity to move to all these other areas of interest. This review describes the role that clinical pharmacology has played at the beginning and during the evolution of pharmacovigilance, pharmacoepidemiology and economic drug evaluations in Spain. In addition, the challenges that clinical pharmacology is going to face in the following years in these three areas are going to be outlined too.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available